http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0018385-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e31f7c32511408c9e44ab16ef5ddf702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e812997df6b730d7faa24159af6a031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd1a266279b31fee6f6c9f2acd3bb494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_135b0bdc6b40aade4e07644b803e86fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48c14bfb4f60afac6889bc61156acdcf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
filingDate 1999-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32bd9c4f5662c1106a157c03e9e4144f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3356fd4bac55f50f4a45ec7791c4d808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bacf55e27d2cbaf776838c0b1017faf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_738621370062dfc83425632942d388d5
publicationDate 2000-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0018385-A2
titleOfInvention Use of acylcarnitines as antitumour agents
abstract Acylcarnitines, such as L-acetylcarnitine (I) were found to have marked antitumour activity, which can be further increased by simultaneous administration of somatostatin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102215838-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008228192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010063698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010063696-A1
priorityDate 1998-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9706788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9734596-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9705862-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0845265-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226490365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16161315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226450366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128916092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288

Total number of triples: 54.